Evolus Inc (EOLS)
$7.35 -2.26% Close Oct 30, 2026 Live
Evolus stock today
Evolus closed at $7.35 on October 30, 2026, down 2.26% on the day. Over the past year it returned +9.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $484 million.
$4.00$6.00$8.00
NovJan 2026MarMayJulSep
| Period | EOLS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.1% | -0.9% |
| 3 months | +22.3% | +2.1% |
| Year to date | +10.5% | +11.7% |
| 1 year | +9.4% | +12.4% |
| 3 years | -3.4% | +88.5% |
| 5 years | -6.0% | +76.0% |
Key statistics
- Market value
- $484M
- Forward P/E
- 60.2
- Price / sales
- 1.5
- 52-week range
- $3.94 to $9.30
- Next report
- Nov 4, 2026
About Evolus
Pharmaceutical company developing and commercializing injectable aesthetic products.
Sector: Health Care
More on Evolus
- Financials: revenue, earnings and segmentsRevenue +12% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $939.90 today
No forecast, no recommendation. This page describes Evolus Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.